Clinical Trial Update: Combination Paclitaxel, Carboplatin and Temozolomide [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating the combination of paclitaxel, carboplatin, and temozolomide for lung cancer has completed. The update summarizes safety and dosing f…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• PACLITAXEL (PACLITAXEL)
• Temozolomide (Temozolomide)

Snippet

Sponsor: New Mexico Cancer Research Alliance | Conditions: Lung Diseases, Cancer | Phase 1 | Status: COMPLETED